Activation of liver X receptor induces macrophage interleukin-5 expression

Journal of Biological Chemistry

Volumn 287, Issue 52, 2012, Pages 43340-43350

  Chen, Yuanli ^a   Duan, Yajun ^a   Kangs, Yanhua ^a   Yang, Xiaoxiao ^a   Jiang, Meixiu ^a   Zhangs, Ling ^a   Li, Guangliang ^a   Yin, Zhinan ^a   Hu, Wenquan ^a   Dong, Pengzhi ^a   Li, Xiaoju ^a   Hajjar, David P ^b   Hans, Jihong ^a  

^a NANKAI UNIVERSITY   (China)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AORTIC ROOT; CHOLESTEROL EFFLUX; IN-VIVO; INTERLEUKIN-5; KNOCK OUTS; LIVER X RECEPTORS; OVER-EXPRESSION; OXIDIZED-LOW DENSITY; PROMOTER ACTIVITIES; PROTEIN EXPRESSIONS; PROTEIN STABILITY; TARGET GENES; WILD TYPES;

DISEASES; LIGANDS; MAMMALS; TISSUE; TRANSCRIPTION FACTORS;

MACROPHAGES;

IMMUNOGLOBULIN M; INTERLEUKIN 5; LIVER X RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR; N (2,2,2 TRIFLUOROETHYL) N [4 [2,2,2 TRIFLUORO 1 HYDROXY 1 (TRIFLUOROMETHOXY)ETHYL]PHENYL]BENZENESULFONAMIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIATHEROGENIC ACTIVITY; ANTIBODY BLOOD LEVEL; AORTA ROOT; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; GENE ACTIVATION; GENE EXPRESSION; GENE OVEREXPRESSION; GENE SILENCING; GENE TARGETING; GENETIC TRANSCRIPTION; IN VIVO STUDY; INTERLEUKIN 5 GENE; LDL RECEPTOR GENE; LXR GENE; LXR RESPONSIVE ELEMENT; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STABILITY; WILD TYPE;

ANIMALS; AORTA; ATHEROSCLEROSIS; ATP-BINDING CASSETTE TRANSPORTERS; CELL LINE; CHOLESTEROL; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HYDROCARBONS, FLUORINATED; IMMUNOGLOBULIN M; INTERLEUKIN-5; MACROPHAGES; MICE; MICE, KNOCKOUT; ORPHAN NUCLEAR RECEPTORS; RESPONSE ELEMENTS; SULFONAMIDES;

MUS;

EID: 84871549478     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.403394     Document Type: Article

References (43)

1. Ley, K., Miller, Y. I., and Hedrick, C. C. (2011) Monocyte and macrophage dynamics during atherogenesis. Arterioscler. Thromb. Vasc. Biol. 31, 1506-1516
2. Mitra, S., Deshmukh, A., Sachdeva, R., Lu, J., and Mehta, J. L. (2011) Oxidized low-density lipoprotein and atherosclerosis implications in antioxidant therapy. Am. J. Med. Sci. 342, 135-142
3. Esterbauer, H., Schaur, R. J., and Zollner, H. (1991) Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 11, 81-128 (Pubitemid 121003917)
4. Palinski, W., Rosenfeld, M. E., Ylä-Herttuala, S., Gurtner, G. C., Socher, S. S., Butler, S. W., Parthasarathy, S., Carew, T. E., Steinberg, D., and Witztum, J. L. (1989) Low density lipoprotein undergoes oxidative modification in vivo. Proc. Natl. Acad. Sci. U.S.A. 86, 1372-1376 (Pubitemid 19061548)
5. Ylä-Herttuala, S., Palinski, W., Rosenfeld, M. E., Parthasarathy, S., Carew, T. E., Butler, S., Witztum, J. L., and Steinberg, D. (1989) Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest. 84, 1086-1095 (Pubitemid 19247577)
6. Hulthe, J. (2004) Antibodies to oxidized LDL in atherosclerosis development. Clinical and animal studies. Clin. Chim. Acta 348, 1-8
7. Palinski, W., Ord, V. A., Plump, A. S., Breslow, J. L., Steinberg, D., and Witztum, J. L. (1994) ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum. Arterioscler. Thromb. 14, 605-616
8. Palinski, W., Tangirala, R. K., Miller, E., Young, S. G., and Witztum, J. L. (1995) Increased autoantibody titers against epitopes of oxidized LDL in LDL receptor-deficient mice with increased atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 15, 1569-1576
9. Karlen, S., De Boer, M. L., Lipscombe, R. J., Lutz, W., Mordvinov, V. A., and Sanderson, C. J. (1998) Biological and molecular characteristics of interleukin-5 and its receptor. Int. Rev. Immunol. 16, 227-247 (Pubitemid 28102255)
10. Hogan, S. P., Koskinen, A., and Foster, P. S. (1997) Interleukin-5 and eosinophils induce airway damage and bronchial hyperreactivity during allergic airway inflammation in BALB/c mice. Immunol. Cell Biol. 75, 284-288 (Pubitemid 27297208)
11. Binder, C. J., Hartvigsen, K., Chang, M. K., Miller, M., Broide, D., Palinski, W., Curtiss, L. K., Corr, M., and Witztum, J. L. (2004) IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis. J. Clin. Invest. 114, 427-437 (Pubitemid 39071615)
12. Apfel, R., Benbrook, D., Lernhardt, E., Ortiz, M. A., Salbert, G., and Pfahl, M. (1994) A novel orphan receptor specific for a subset of thyroid hormone-responsive elements and its interaction with the retinoid/thyroid hormone receptor subfamily. Mol. Cell. Biol. 14, 7025-7035
13. Willy, P. J., Umesono, K., Ong, E. S., Evans, R. M., Heyman, R. A., and Mangelsdorf, D. J. (1995) LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev. 9, 1033-1045
14. Im, S. S., and Osborne, T. F. (2011) LiverXreceptors in atherosclerosis and inflammation. Circ. Res. 108, 996-1001
15. Parikh, N., and Frishman, W. H. (2010) Liver X receptors. A potential therapeutic target for modulating the atherosclerotic process. Cardiol. Rev. 18, 269-274
16. Tangirala, R. K., Bischoff, E. D., Joseph, S. B., Wagner, B. L., Walczak, R., Laffitte, B. A., Daige, C. L., Thomas, D., Heyman, R. A., Mangelsdorf, D. J., Wang, X., Lusis, A. J., Tontonoz, P., and Schulman, I. G. (2002) Identification of macrophage liver X receptors as inhibitors of atherosclerosis. Proc. Natl. Acad. Sci. U.S.A. 99, 11896-11901 (Pubitemid 34994495)
17. Joseph, S. B., Bradley, M. N., Castrillo, A., Bruhn, K. W., Mak, P. A., Pei, L., Hogenesch, J., O'Connell R, M., Cheng, G., Saez, E., Miller, J. F., and Tontonoz, P. (2004) LXR-dependent gene expression is important for macrophage survival and the innate immune response. Cell 119, 299-309 (Pubitemid 39360910)
18. Joseph, S. B., Castrillo, A., Laffitte, B. A., Mangelsdorf, D. J., and Tontonoz, P. (2003) Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat. Med. 9, 213-219 (Pubitemid 36227724)
19. Zhou, X., Yin, Z., Guo, X., Hajjar, D. P., and Han, J. (2010) Inhibition of ERK1/2 and activation of liver X receptor synergistically induce macrophage ABCA1 expression and cholesterol efflux. J. Biol. Chem. 285, 6316-6326
20. Duan, Y., Chen, Y., Hu, W., Li, X., Yang, X., Zhou, X., Yin, Z., Kong, D., Yao, Z., Hajjar, D. P., Liu, L., Liu, Q., and Han, J. (2012) Peroxisome proliferator-activated receptor γ activation by ligands and dephosphorylation induces proprotein convertase subtilisin kexin type 9 and low density lipoprotein receptor expression. J. Biol. Chem. 287, 23667-23677
21. Terasaka, N., Hiroshima, A., Koieyama, T., Ubukata, N., Morikawa, Y., Nakai, D., and Inaba, T. (2003) T-0901317, a synthetic liver X receptor ligand, inhibits development of atherosclerosis in LDL receptor-deficient mice. FEBS Lett. 536, 6-11 (Pubitemid 36206397)
22. Joseph, S. B., McKilligin, E., Pei, L., Watson, M. A., Collins, A. R., Laffitte, B. A., Chen, M., Noh, G., Goodman, J., Hagger, G. N., Tran, J., Tippin, T. K., Wang, X., Lusis, A. J., Hsueh, W. A., Law, R. E., Collins, J. L., Willson, T. M., and Tontonoz, P. (2002) Synthetic LXR ligand inhibits the development of atherosclerosis in mice. Proc. Natl. Acad. Sci. U.S.A. 99, 7604-7609 (Pubitemid 34568738)
23. Steinberg, D., Parthasarathy, S., Carew, T. E., Khoo, J. C., and Witztum, J. L. (1989) Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. New Engl. J. Med. 320, 915-924 (Pubitemid 19101597)
24. Linton, M. F., and Fazio, S. (2001) Class A scavenger receptors, macrophages, and atherosclerosis. Curr. Opin. Lipidol. 12, 489-495 (Pubitemid 32980296)
25. Frostegård, J. (2002) Autoimmunity, oxidized LDL and cardiovascular disease. Autoimmun. Rev. 1, 233-237
26. Miller, Y. I., Chang, M. K., Binder, C. J., Shaw, P. X., and Witztum, J. L. (2003) Oxidized low density lipoprotein and innate immune receptors. Curr. Opin. Lipidol. 14, 437-445 (Pubitemid 37297298)
27. Binder, C. J., Chou, M. Y., Fogelstrand, L., Hartvigsen, K., Shaw, P. X., Boullier, A., and Witztum, J. L. (2008) Natural antibodies in murine atherosclerosis. Curr. Drug Targets 9, 190-195 (Pubitemid 351843599)
28. Stemme, S., Faber, B., Holm, J., Wiklund, O., Witztum, J. L., and Hansson, G. K. (1995) T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc. Natl. Acad. Sci. U.S.A. 92, 3893-3897
29. Palinski, W., Hörkkö, S., Miller, E., Steinbrecher, U. P., Powell, H. C., Curtiss, L. K., and Witztum, J. L. (1996) Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma. J. Clin. Invest. 98, 800-814 (Pubitemid 26349186)
30. Chou, M. Y., Hartvigsen, K., Hansen, L. F., Fogelstrand, L., Shaw, P. X., Boullier, A., Binder, C. J., and Witztum, J. L. (2008) Oxidation-specific epitopes are important targets of innate immunity. J. Int. Med. 263, 479-488 (Pubitemid 351533561)
31. Ylä-Herttuala, S., Palinski, W., Butler, S. W., Picard, S., Steinberg, D., and Witztum, J. L. (1994) Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. Arterioscler. Thromb. 14, 32-40
32. Tsimikas, S., Palinski, W., and Witztum, J. L. (2001) Circulating autoantibodies to oxidized LDL correlate with arterial accumulation and depletion of oxidized LDL in LDL receptor-deficient mice. Arterioscler. Thromb. Vasc. Biol. 21, 95-100 (Pubitemid 32061933)
33. Hörkkö, S., Bird, D. A., Miller, E., Itabe, H., Leitinger, N., Subbanagounder, G., Berliner, J. A., Friedman, P., Dennis, E. A., Curtiss, L. K., Palinski, W., and Witztum, J. L. (1999) Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins. J. Clin. Invest. 103, 117-128 (Pubitemid 29031170)
34. Karvonen, J., Päivänsalo, M., Kesäniemi, Y. A., and Hörkkö, S. (2003) Immunoglobulin M type of autoantibodies to oxidized low-density lipoprotein has an inverse relation to carotid artery atherosclerosis. Circulation 108, 2107-2112 (Pubitemid 37337587)
35. Caligiuri, G., Nicoletti, A., Poirier, B., and Hansson, G. K. (2002) Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice. J. Clin. Invest. 109, 745-753 (Pubitemid 34263151)
36. Binder, C. J., Hörkkö, S., Dewan, A., Chang, M. K., Kieu, E. P., Goodyear, C. S., Shaw, P. X., Palinski, W., Witztum, J. L., and Silverman, G. J. (2003) Pneumococcal vaccination decreases atherosclerotic lesion formation. Molecular mimicry between Streptococcus pneumoniae and oxidized LDL. Nat. Med. 9, 736-743 (Pubitemid 36749223)
37. Shaw, P. X., Hörkkö, S., Chang, M. K., Curtiss, L. K., Palinski, W., Silverman, G. J., and Witztum, J. L. (2000) Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J. Clin. Invest. 105, 1731-1740
38. Kouro, T., and Takatsu, K. (2009) IL-5- and eosinophil-mediated inflammation. From discovery to therapy. Int. Immunol. 21, 1303-1309
39. Sämpi, M., Ukkola, O., Päivänsalo, M., Kesäniemi, Y. A., Binder, C. J., and Hörkkö, S. (2008) Plasma interleukin-5 levels are related to antibodies binding to oxidized low-density lipoprotein and to decreased subclinical atherosclerosis. J. Am. Coll. Cardiol. 52, 1370-1378
40. Lasser, E. C., Berry, C., and Kortman, K. (1987) Diminished atherosclerotic arterial calcifications in asthma. A possible role for elevated endogenous heparin-like material. Allergy 42, 549-552 (Pubitemid 17138791)
41. Naora, H., van Leeuwen, B. H., Bourke, P. F., and Young, I. G. (1994) Functional role and signal-induced modulation of proteins recognizing the conserved TCATTT-containing promoter elements in the murine IL-5 and GM-CSF genes in T lymphocytes. J. Immunol. 153, 3466 -3475
42. Masuda, E. S., Tokumitsu, H., Tsuboi, A., Shlomai, J., Hung, P., Arai, K., and Arai, N. (1993) The granulocyte-macrophage colony-stimulating factor promoter cis-acting element CLE0 mediates induction signals in T cells and is recognized by factors related to AP1 and NFAT. Mol. Cell. Biol. 13, 7399-7407 (Pubitemid 23354264)
43. Kim, K. H., Yoon, J. M., Choi, A. H., Kim, W. S., Lee, G. Y., and Kim, J. B. (2009) Liver X receptor ligands suppress ubiquitination and degradation of LXRα by displacing BARD1/BRCA1. Mol. Endocrinol. 23, 466-474